Effect of Pretransplant Hepatitis C Virus RNA Status on Posttransplant Outcome

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1449-1455

  Nudo, C G ^a   Cortes, R A ^a   Weppler, D ^a   Schiff, E R ^a   Tzakis, A G ^a   Regev, A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INTERFERON; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; RAPAMYCIN; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GRAFT FAILURE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; FEMALE; GRAFT SURVIVAL; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RNA, VIRAL; SURVIVAL RATE; TREATMENT OUTCOME; VIRAL LOAD;

EID: 45449118288     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.158     Document Type: Article

References (27)

1. World Health Organization: Weekly Epidemiological Record 49; 10 December 1999
2. World Health Organization. Hepatitis C fact sheet 164; revised October 2000. http://www.who.int/mediacentre/factsheets/fs164/en/ Accessed December 21, 2006
3. Liang T.J., Rehermann B., Seeff L.B., et al. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132 (2000) 296
4. Sangiovanni A., Prati G.M., Fasani P., et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 43 (2006) 1303
5. Seeff L.B., Buskell-Bales Z., Wright E.C., et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med 327 (1992) 1906
6. Davis G.L. Chronic hepatitis C and liver transplantation. Rev Gastroenterol Disord 4 (2004) 7
7. Guerrero R.B., Batts K.P., Burgart L.J., et al. Early detection of hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study. Mod Pathol 13 (2000) 229
8. Gane E.J., Naoumov N.V., Qian K.P., et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 110 (1996) 167
9. Testa G., Crippin J.S., Netto G.J., et al. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl 6 (2000) 553
10. Gane E.J., Portmann B.C., Naoumov N.V., et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334 (1996) 815
11. Berenguer M., Ferrell L., Watson J., et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 32 (2000) 673
12. Neumann U., Berg T., Bahra M., et al. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C. J Hepatol 41 (2004) 830
13. Wiesner R., Sorrell M., Villamil F., and International Liver Transplantation Society Expert Panel. Report of the first International Liver Transplantation Society Expert Panel consensus conference on liver transplantation and hepatitis C. Liver Transpl 9 (2003) S1
14. Burak K.W., Kremers W.K., Batts K.P., et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl 8 (2002) 362
15. Lake J.R., Shorr J.S., Steffen B.J., et al. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 5 (2005) 549
16. Rifai K., Sebagh M., Karam V., et al. Donor age influences 10-year liver graft histology independently of hepatitis C virus infection. J Hepatol 41 (2004) 446
17. Sheiner P., Schwartz M., Mor E., et al. Severe and multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 21 (1995) 30
18. Rosen H., Shackleton C., Higa L., et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 92 (1997) 1453
19. Prieto M., Berenguer M., Rayon J.M., et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. Hepatology 29 (1999) 250
20. Charlton M., Seaberg E., Wiesner R., et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 28 (1998) 823
21. Everson G., Trotter J., Forman L., et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy. Hepatology 42 (2005) 255
22. Forns X., Navasa M., and Rodes J. Treatment of HCV infection in patients with advanced cirrhosis. Hepatology 40 (2004) 498
23. Forns X., Garcia-Retortillo M., Serrano T., et al. Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol 39 (2003) 389
24. Thomas R.M., Brems J.J., Guzman-Hartman G., et al. Infection with chronic hepatitis C virus and liver transplantation: a role for interferon therapy before transplantation. Liver Transpl 9 (2003) 905
25. Ludwig J., and Lefkowitch J. Histopathology of the liver following transplantation. In: Maddrey W., Schiff E., and Sorrell M. (Eds). Transplantation of the Liver (2001), Lippincott Williams & Wilkins, Philadelphia 229
26. Rosen H.R., and Martin P. Liver transplantation. In: Schiff E., Sorrell M., and Maddrey W. (Eds). Schiff's Diseases of the liver. 8th Ed. (1988), Lippincott Williams & Wilkins, Philadelphia 1589
27. Busuttil R.W., Farmer D.G., Yersiz H., et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg 241 (2005) 905